Poison center calls about kratom exploded by over 1,200% in a decade, hitting a record 3,434 cases in 2025 alone, leaving doctors desperate to warn users before more lives are lost.
Story Snapshot
- Kratom poison reports surged 1,200% from 258 in 2015 to 3,434 in 2025, per national data.
- Hospitalizations jumped 1,150% for solo kratom use, reaching 538 cases last year.
- 233 deaths linked to kratom over 10 years, 79% involving other drugs.
- Men in 20s-30s dominate cases, but 40-59 group saw sharp rises too.
- Experts demand regulation amid unregulated, potent products flooding markets.
Kratom’s Rapid Rise in Poison Center Data
U.S. poison centers logged 14,449 kratom exposures from 2015 to 2025. Reports climbed steadily until 2019, plateaued through 2024, then spiked dramatically in 2025. This surge correlates with wider availability in vape shops, gas stations, and online. Stronger formulations containing mitragynine and 7-hydroxymitragynine drive the potency increase. Men aged 20-39 lead exposures, yet adults 40-59 now match their rates, signaling broader adoption across generations.
Hospitalizations and Deaths Climb Alarmingly
Hospitalizations from kratom alone rose 1,150%, from 43 cases in 2015 to 538 in 2025. Cases mixing kratom with drugs or antidepressants surged 1,300%, hitting 549. In 2025, 60% of multi-substance reports yielded serious outcomes; half needed hospital stays. Total deaths reached 233, with 184 tied to polydrug use. These numbers reflect unregulated markets fueling riskier products and combinations.
Doctors Sound the Alarm on Unseen Dangers
Chris Holstege, MD, directs UVA Health’s Blue Ridge Poison Center and flags kratom’s complex pharmacology. Chemicals interact dangerously with alcohol, meds, or illicit drugs, causing nausea, seizures, dependence, and worse. Rita Farah, PhD, MPH, PharmD, led the analysis showing demographic shifts. Experts call for surveillance and education, as kratom’s opioid-like effects mimic relief but hide addiction traps.
Stakeholders Clash Over Kratom’s Fate
FDA and DEA push safety measures like import alerts, facing resistance from American Kratom Association advocates who tout harm reduction for opioid withdrawal. Doctors and AMA highlight risks backed by data; users and retailers defend access for pain management. NIH researchers split: some see tapering potential, others cardiac threats. This divide echoes values prizing personal responsibility against unchecked markets breeding black market perils.
Impacts Ripple Through Healthcare and Policy
Emergency rooms strain under acute toxicity waves, hitting high-use communities hardest. Long-term, bans could spike contaminated street sales, disrupting legitimate pain relief for millions. The multi-billion industry influences supplement rules, paralleling CBD fights. Rural areas lean on kratom as opioid alternatives, yet data urges balanced reform over outright prohibition to safeguard families without nanny-state overreach.
Sources:
Kratom cases are exploding across the U.S. and doctors are alarmed
Kratom Calls Skyrocket to Nation’s Poison Centers – UVA Health
Increases in Kratom-Related Reports to Poison Centers – CDC
[PDF] Increases in Kratom-Related Reports to Poison Centers – CDC
